Suchergebnisse - "Jardine, Meg J"

PubPharm (160)

1

Applications of SGLT2 inhibitors beyond glycaemic control

enthalten in: Nature reviews. Nephrology | 2024

von O'Hara, D. | Lam, C. | McMurray, J. | +6

2

The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice dataset

enthalten in: bioRxiv.org | 2024

von Jun, M. | Wick, J. | Neuen, B. | +11

3

Not enough known about fenofibrate's kidney effects in people with Type 2 diabetes

enthalten in: Diabetes research and clinical practice | 2024

von Jenkins, A. | O'Connell, R. | Januszewski, A. | +7

4

Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease : a meta-analysis of CKD progression trials

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2024

von Fletcher, R. | Herrington, W. | Agarwal, R. | +10

5

Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes : A SMART-C Collaborative Meta-Analysis

enthalten in: Circulation | 2024

von Patel, S. | Kang, Y. | Im, K. | +26

6

Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region : report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

enthalten in: Kidney international supplements | 2024

von Francis, A. | Wainstein, M. | Irish, G. | +77

CommentIn: Kidney Int Suppl (2011). 2024 Apr;13(1):1-5. - PMID 38619132

7

The Prevalence of CKD in Australian Primary Care : Analysis of a National General Practice Dataset

enthalten in: Kidney international reports | 2024

von Jun, M. | Wick, J. | Neuen, B. | +11

8

Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research

enthalten in: Canadian journal of kidney health and disease | 2024

von Yi, T. | O'Hara, D. | Smyth, B. | +3

9

Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease : a cross-sectional observational study using routinely collected Australian primary care data

enthalten in: The Lancet regional health. Western Pacific | 2024

von Neuen, B. | Jun, M. | Wick, J. | +11

10

Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade : A Joint Analysis of the CREDENCE and DAPA-CKD Trials

enthalten in: Journal of the American Society of Nephrology : JASN | 2023

von Fletcher, R. | Jongs, N. | Chertow, G. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]